AbCellera Biologics Clears Key Benchmark, Hitting 80-Plus RS Rating
AbCellera Biologics saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 77 to 81. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. This exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score.